Sale!

MYL3 Gene Cardiomyopathy familial hypertrophic type 8 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The MYL3 Gene Cardiomyopathy Familial Hypertrophic Type 8 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the MYL3 gene, which are associated with familial hypertrophic cardiomyopathy (HCM) type 8. This condition is a form of heart disease that is inherited in an autosomal dominant pattern, where the heart muscle becomes abnormally thick, making it harder for the heart to pump blood. The MYL3 gene plays a crucial role in encoding the myosin light chain, a component essential for the contraction of heart muscles.

The test, priced at 4400 AED, involves collecting a DNA sample from the patient, typically through a blood draw or cheek swab. This sample is then analyzed in the lab to detect any genetic variations that may indicate a predisposition to this form of cardiomyopathy. Early detection through this genetic test can be pivotal in managing the condition, allowing for timely interventions and personalized treatment plans to mitigate the risk of complications such as heart failure or sudden cardiac death.

DNA Labs UAE, known for its state-of-the-art facilities and expert team, ensures a reliable and efficient testing process, providing crucial information for individuals with a family history of HCM or those exhibiting symptoms related to the condition. This test not only aids in the diagnosis but also helps in the risk assessment for family members, guiding decisions on the need for further genetic counseling or testing.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MYL3 Gene Cardiomyopathy familial hypertrophic type 8 Genetic Test

At DNA Labs UAE, we offer the MYL3 Gene Cardiomyopathy familial hypertrophic type 8 Genetic Test. This test is designed to diagnose familial hypertrophic cardiomyopathy (FHC), a genetic disorder that affects the heart muscle.

Test Details

FHC is characterized by the thickening of the heart muscle, which can lead to problems with the heart’s ability to pump blood effectively. Our MYL3 Gene Cardiomyopathy familial hypertrophic type 8 Genetic Test uses NGS (Next-Generation Sequencing) technology to analyze multiple genes simultaneously.

Components and Price

The cost of the MYL3 Gene Cardiomyopathy familial hypertrophic type 8 Genetic Test is 4400.0 AED. The test can be performed using a blood sample, extracted DNA, or one drop of blood on an FTA Card.

Report Delivery

Once the sample is received, the report will be delivered within 3 to 4 weeks.

Test Type

The MYL3 Gene Cardiomyopathy familial hypertrophic type 8 Genetic Test falls under the category of Cardiovascular Pneumology Disorders.

Doctor and Test Department

This test is performed by a cardiologist in our Genetics department.

Pre Test Information

Prior to the test, it is important to provide the clinical history of the patient who is going for the MYL3 Gene Cardiomyopathy familial hypertrophic type 8 NGS Genetic DNA Test. A genetic counseling session will be conducted to draw a pedigree chart of family members affected with MYL3 Gene Cardiomyopathy, familial hypertrophic type 8 NGS Genetic DNA Test gene MYL3.

Benefits of the Test

By performing the MYL3 Gene Cardiomyopathy familial hypertrophic type 8 Genetic Test, doctors and genetic counselors can provide individuals with a diagnosis and better understanding of their risk for developing familial hypertrophic cardiomyopathy. This information can be used to guide treatment decisions, monitor disease progression, and provide guidance for family members who may also be at risk.

Important Note

It is important to note that genetic testing should be done under the guidance of a healthcare professional, such as a genetic counselor or medical geneticist, who can provide appropriate counseling and support throughout the testing process.

Test Name MYL3 Gene Cardiomyopathy familial hypertrophic type 8 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cardiovascular Pneumology Disorders
Doctor Cardiologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for MYL3 Gene Cardiomyopathy, familial hypertrophic type 8 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MYL3 Gene Cardiomyopathy, familial hypertrophic type 8 NGS Genetic DNA Test gene MYL3
Test Details

The MYL3 gene is associated with familial hypertrophic cardiomyopathy (FHC), which is a genetic disorder that affects the heart muscle. FHC is characterized by the thickening of the heart muscle, leading to problems with the heart’s ability to pump blood effectively.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of familial hypertrophic cardiomyopathy, NGS genetic testing can identify mutations in the MYL3 gene that may be responsible for the development of the condition.

By performing NGS genetic testing for MYL3 gene cardiomyopathy, doctors and genetic counselors can provide individuals with a diagnosis and better understanding of their risk for developing familial hypertrophic cardiomyopathy. This information can be used to guide treatment decisions, monitor disease progression, and provide guidance for family members who may also be at risk.

It is important to note that genetic testing should be done under the guidance of a healthcare professional, such as a genetic counselor or medical geneticist, who can provide appropriate counseling and support throughout the testing process.